issues
Nasal & Inhalation eBook 2026
Download PDFCOVER
2026 Inhalation & Nasal Drug Development & Delivery eBook: Drug Repurposing Creates New Market Opportunities
In this exclusive seventh annual inhalation and nasal eBook, Cindy H. Dubin discusses how these routes of administration are bringing new life to orphaned drugs and open new opportunities for treatment beyond pulmonary and respiratory diseases.
FEATURES
NeuroSpray™: A High-Precision Multi-Dose Nasal Pump Platform Engineered for Nose-to-Brain Performance
Reenal Gandhi explains the challenges of nose-to-brain (N2B) drug delivery and highlights Aptar Pharma’s NeuroSpray™ as a viable N2B configuration designed exclusively for central nervous systems (CNS)-focused applications.
Orbital™: Advancing High-Payload Pulmonary Delivery Through Precision, Usability, & System Level Design
Jonathan Mulpas describes limitations of traditional dry power inhalers (DPIs) and how Aptar Pharma positions its Orbital DPI platform as a high-payload inhalation platform intended for complex and high-value therapies.
De-risking the Green Transition: A Digital-First Approach to Low Carbon pMDIs
Tom Daly and Karl Bass disclose how next-generation propellants have distinct properties that impact how formulations will behave. As a specialist inhalation CDMO, Bespak manages those complexities with a computational simulation that reduces risk and accelerates decision-making.
Unlocking the Potential of Nasal Drug Delivery: Strategies for Formulation Success
Dr. Jon Lenn, Dr. Charles Evans, and Dr. Jon Volmer reveal how MedPharm has been refining its strategies to help developers navigate the anatomical and physiological challenges of nasal topical delivery.
